Ellen M. Kerkhof
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
NTCP models predicting bowel toxicity after total neoadjuvant treatment or chemoradiation for rectal cancer in the RAPIDO trial.
Journal: International journal of radiation oncology, biology, physics
Published: November 26, 2025
Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.
Journal: The Lancet. Oncology
Published: November 26, 2025
"Erratum to keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy" [Brachytherapy Volume 23, ISSUE 2, P188-198, March 2024].
Journal: Brachytherapy
Published: January 16, 2025
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma.
Journal: Clinical and translational radiation oncology
Published: December 11, 2024
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.
Journal: Cancers
Published: August 31, 2021
Applicator visualization using ultrashort echo time MRI for high-dose-rate endorectal brachytherapy.
Applicator visualization using ultrashort echo time MRI for high-dose-rate endorectal brachytherapy.
Journal: Brachytherapy
Published: February 23, 2020
Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.
Journal: Radiation oncology (London, England)
Published: October 09, 2019
Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer - A multicentre dose planning study.
Journal: Technical innovations & patient support in radiation oncology
Published: July 08, 2019
Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: March 20, 2019
Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 10, 2018
EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types.
Journal: Endoscopy international open
Published: October 03, 2018
Last Updated: 09/26/2026